Subscribe to MDT Magazine News

Pathfinder, SyntheMed merge

December 23, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Pathfinder LLC, a private Cambridge cell-based therapeutics firm, and New Jersey biomaterials firm SyntheMed Inc. have merged, the two companies announced Wednesday. The newly formed company will be called Pathfinder Cell Therapy Inc. and have its headquarters in Cambridge.

Significant improvement in LED fundamental and manufacturing technologies needed for massive adoption in general lighting applications

December 23, 2010 7:32 am | by I-Micronews | Comments

Yole Développement (Lyon, France) and EPIC (Paris, France) announce the publication of their new market & technological study dedicated to LED industry: LED ManTech Report.

New CVS Caremark Study Finds Health Information Technology May Help Promote Adherence, But More Information and Direction Needed

December 23, 2010 7:31 am | by Bio-Medicine.Org | Comments

WOONSOCKET, R.I., Dec. 23, 2010 /- A new study that reviews more than four decades of medical journal articles about the impact of health information technology (HIT) and electronic communications on medication adherence concludes that while there is evidence to suggest that simple...


Cannabis Science Forms Military Advisory Board That Will Be Comprised of Distinguished Military Leaders, Military Health Care Providers, Researchers and Educators Headed Up by...

December 23, 2010 7:31 am | by Bio-Medicine.Org | Comments

COLORADO SPRINGS, Colo., Dec. 23, 2010 /- Cannabis Science, Inc. (OTC Bulletin Board: CBIS ), a pioneering U.S. biotech company developing pharmaceutical cannabis products, announced today that it has formed a Military Advisory Board, that will be comprised of distinguished military...


BioRelix lands $2.4M financing

December 23, 2010 6:33 am | by Mass High Tech: The Journal of New England Technology | Comments

BioRelix Inc., a New Haven, Conn.-based biotech focused on developing infectious disease treatments, has taken in $2.4 million of a planned $4.8 million debt and warrants financing, according to a regulatory filing.

Fruta Planta: Public Notification - Undeclared Drug Ingredient

December 23, 2010 6:31 am | by U.S. Food & Drug Administration | Comments

Product marketed as a dietary supplement contains sibutramine, a controlled substance known to substantially increase blood pressure and/or pulse rate, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.


RockHard Weekend, Pandora: Recall - Undeclared Drug Ingredient

December 23, 2010 6:30 am | by U.S. Food & Drug Administration | Comments

Product marketed as dietary supplement contains undeclared analogue of sildenafil, a drug which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.


Cephalon names J. Kevin Buchi CEO

December 23, 2010 4:45 am | by The Associated Press | Comments

Cephalon Inc. on Thursday named J. Kevin Buchi as CEO and a member of the company's board of directors, making his temporary responsibilities at the biotechnology company permanent.Buchi, the company's chief operating officer, had taken over the CEO responsibilities in August after Frank...


SU scientists find that in the evolutionary mating game, brawn and stealth rule

December 23, 2010 4:37 am | by EurekAlert | Comments

(Syracuse University) When prowling for a hook up, it's not always the good-looker who gets the girl. In fact, in a certain species of South American fish, brawn and stealth beat out colorful and refined almost every time.


MiMedx Receives Additional CE Certification for Its HydroFixâ„¢ Technology

December 23, 2010 4:35 am | by Bio-Medicine.Org | Comments

MARIETTA, Ga., Dec. 23, 2010 /- MiMedx Group, Inc. (OTC Bulletin Board: MDXG ), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification of the Class III certification for a European product using...


Masimo to Present at 29th Annual J.P. Morgan Healthcare Conference

December 23, 2010 4:33 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., Dec. 23, 2010 /PRNewswire / -- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Tuesday, January 11, 2011, at 11:30 a.m. PT.  A...


Vets-in-training helping elderly keep animals

December 23, 2010 12:45 am | by KRISTEN WYATT - Associated Press - Associated Press | Comments

A fun-loving schnauzer named Pocket is stroke survivor Dorothy Kiser's closest companion. But Kiser almost had to put Pocket to sleep when her pet developed diabetes: Kiser feared she wouldn't be able to take care of the dog alone.Aspiring veterinary students at Colorado State University...

Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test(2)

December 22, 2010 5:34 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, Dec. 22, 2010 /- Sequenom, Inc. (Nasdaq: SQNM ) today announced that the company's wholly-owned reference laboratory, the Sequenom Center for Molecular Medicine (Sequenom CMM), has authorized commencement of a pivotal clinical validation study. This validation study is designed...


Immunotec Mourns Passing of Senior VP - Dr. Wulf Droge, Ph.D.

December 22, 2010 12:45 pm | by The Associated Press | Comments

It is with deep sadness that Immunotec Inc. (TSX VENTURE: IMM) announces the death of its colleague, leader and friend, Dr. Wulf Droge, Senior Vice- President, Research & Development.Dr. Droge, was a world-renowned scientist with more than forty years in basic and clinical research and...

Fraunhofer MEVIS and the University of Bern cooperate with the leading liver center in Shanghai

December 22, 2010 12:35 pm | by EurekAlert | Comments

(Fraunhofer-Gesellschaft) Today, challenging liver surgery is frequently planned and optimized with regard to associated risks with the support of a computer. Based on radiological image data, the liver vessels and tumors are analyzed to produce a patient-individual...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.